Introduction
============

Fibronectin is a multidomain glycoprotein found ubiquitously in human body fluids and extracellular matrices (ECM) of a variety of human tissues and organs, including intestinal epithelial cells ([@B52]; [@B33]) (**Figure [1](#F1){ref-type="fig"}**). After secretion, fibronectin molecules bind to transmembrane integrins, which facilitate dimerization and cytoskeletal coupling ([@B104]). The integrin-bound fibronectin is capable of binding to ECM components such as collagen and laminin. Human fibronectin plays a major role in the regulation of cell migration, tissue repair, and adhesion. Fibronectin is also a common target for bacterial adhesins in the gastrointestinal tract.

![**Schematic diagram of extracellular matrix (ECM) components in the intestinal epithelium.** The epithelial layer is comprised of simple columnar epithelial cells (pink). Goblet cells (blue) secrete mucin for cell lubrication and protection. Fibroblasts (dark green) synthesize components of the ECM, including fibronectin. The gut microbiota (green ovals) consists of a complex community of microorganisms that inhabit the gastrointestinal tract of animals.](fmicb-07-01504-g001){#F1}

After its discovery in the mid-1970s, fibronectin was described as a non-integral glycoprotein that mediates attachment to fibroblasts and hepatocytes ([@B52]; [@B68]). Researchers first showed that *Staphylococcus aureus* binds to fibronectin *in vitro* ([@B71]). In the nearly 40 years since the discovery of fibronectin-bacterial interactions, fibronectin-binding proteins (FnBPs) have been identified in both Gram-positive and Gram-negative bacteria, including pathogens and commensals. Notably, no common sequence features have been identified among the large collection of known FnBPs. To further complicate the classification of bacterial FnBPs, single bacterial species often contain multiple, diverse FnBPs. In this review, we describe the interaction between human fibronectin structures and bacterial adhesins by highlighting the FnBPs of Gram-positive pathogens and commensals. We provide an overview of the multiplicity and diversity of FnBPs, with a focus on the model pathogenic organisms in which FnBPs are best characterized.

Fibronectin Structure
=====================

The mature form of fibronectin exists as a heterodimer linked by two C-terminal disulfide bonds ([@B67]) (**Figure [2](#F2){ref-type="fig"}**). There are two distinct forms of mature fibronectin: soluble and insoluble. Soluble fibronectin is produced by liver cells and secreted into the bloodstream. Meanwhile, fibroblasts and endothelial cells synthesize insoluble, cellular fibronectin. Cellular fibronectin is involved in cell adhesion, migration, and the deposition of other ECM proteins ([@B69]; [@B113]). In general, fibronectin consists of 12 FN type I repeats (FNI), 2 FN type II repeats (FNII), and 15 FN type III repeats (FNIII). The modular structure of insoluble fibronectin can include two alternatively spliced FNIII domains (EIIIA/EIIIB) and one FNIII connecting segment (IIICS). Notably, soluble fibronectin does not contain the EIIIA and EIIIB domains ([@B122]; [@B130]). Though both forms of fibronectin are encoded by a single gene, they contain different arrangements of domains due to alternative splicing ([@B106]). In fact, 20 isoforms of insoluble fibronectin have been identified in humans ([@B29]). Specific domain organizations are responsible for interaction with other host proteins, including collagen, laminin, integrin, and fibrin ([@B26]; [@B81]; [@B41]; [@B118]; [@B98]). Modifications to subdomain structure have been shown to affect structural conformation of fibronectin, thus affecting the presentation of domains ([@B97]). Changes in loop structures and domain availability can alter the intricate and specific interactions of fibronectin with its surroundings ([@B115]).

![**Schematic diagram of the multidomain architecture of a cellular fibronectin heterodimer, consisting of 12 FN type I repeats (FNI), 2 FN type II repeats (FNII), and 15 FN type III repeats (FNIII).** The lower branch contains splice variants, which can include two alternatively spliced FNIII domains (EIIIA/EIIIB) and one FNIII connecting segment (IIICS). The presence and arrangement of these domains are responsible for interaction with bacterial FnBPs (red) and host proteins (black).](fmicb-07-01504-g002){#F2}

The N-terminal FNI~1~--FNI~5~ modules were the first domains in fibronectin shown to interact specifically with bacteria ([@B85]). As many FnBPs have since been shown to bind to this region, the FNI~1~--FNI~5~ modules represent the canonical bacterial binding site on fibronectin. These domains are also required for binding to heparin, fibroblasts, and fibrin ([@B114]; [@B98]). However, the FNI~4~--FNI~5~ modules alone are sufficient to bind fibrin ([@B79]). The FNI~1~--FNI~5~ modules are required for proper assembly of the ECM, as well as self-interaction with FNIII domains ([@B105]; [@B125]).

The region immediately downstream of the FNI~1~--FNI~5~ modules, consisting of the domains FNI~6~FNII~1-2~FNI~7-9~, is necessary for binding collagen ([@B91],[@B92]; [@B5]). This region is also a non-canonical bacterial binding site for select FnBPs in *Streptococcus pyogenes* ([@B109]). Additional non-canonical bacterial binding sites are located at the FNIII~12~ module and FNIII~9~--FNIII~10~ modules, which have been shown to bind FnBPs from *Staphylococcus epidermidis* and *Clostridium perfringens* ([@B15]; [@B65]). The FNIII~12~--FNIII~14~ modules are necessary for heparin binding, although FNIII~13~ has been identified as the primary binding site ([@B87]; [@B56]). A second fibrin-binding site is located at the C-terminal FNI~10~--FNI~12~ modules ([@B102]; [@B129]).

Fibronectin attaches to the host cell surface via membrane-spanning α~5~β~1~ integrin receptor molecules ([@B53]). Integrins bind fibronectin at the RGD loop of the FNIII~10~ module and the adjacent PHSRN sequence of the FNIII~9~ module ([@B118]; [@B3]). By this mechanism, fibronectin, integrin, and FnBPs form a three-component bridge between host cells and bacterial cells ([@B112]).

Fibronectin-Binding Proteins
============================

In 1978, researchers showed that *S. aureus* binds to fibronectin *in vitro* ([@B71]; [@B28]; [@B35]). The proteins FnBPA and FnBPB were initially identified as FnBPs in *S. aureus* ([@B31]; [@B63]). The two proteins contain N-terminal signal peptides with the YSIRK/GS motif that direct the proteins to localize at the cell surface, while a C-terminal region with the LPXTG motif anchors them to the cell wall ([@B110]; [@B4]; [@B22]). Once anchored to the cell wall, an array of fibronectin-binding repeats (FnBRs) mediates direct interactions with fibronectin ([@B108]). Originally, a series of 38-amino acid C-terminal repeats were thought to constitute the FnBPA binding site ([@B110]). However, the binding site has since expanded to contain 11 tandem repeats in FnBPA and 10 tandem repeats in FnBPB, with each repeat consisting of 30--40 amino acids ([@B78]; [@B108]). These domains bind fibronectin with differing affinities at the N-terminal five-module region (FNI~1~--FNI~5~) by a tandem β-zipper model ([@B60]; [@B82]). Recent studies examine the structure of FnBPA in complex with fibronectin and reveal the role of each domain in fibronectin attachment ([@B6]; [@B11]). These findings suggest multivalent binding between a single copy of FnBPA/B and multiple fibronectin molecules.

Studies on FnBPA and FnBPB of *S. aureus* are guided by an interest in virulence factors of model pathogenic organisms. However, *S. aureus* expresses many other FnBPs that contribute to the complexity of bacterial adherence to host ligands. The largest of these is 1.1-MDa Ebh (\>10,000 amino acids), a surface protein with 44 imperfect repeats of 126 amino acids ([@B17]). Ebh is tightly associated with the bacterial cell surface despite the absence of an LPXTG motif. A region within the central repeat sequence has been identified as the binding site for fibronectin ([@B17]). Recent studies on *S. aureus* show that inactivation of Ebh leads to a drastic increase in cell volume with irregular shape and thickness, suggesting Ebh plays a major role in cell growth and envelope assembly ([@B13]). An additional FnBP in *S. aureus*, the 15-kDa cell wall-attached protein Eap, mediates fibronectin binding using an alternative cell wall-anchoring mechanism in which externally added protein can bind cells of *S. aureus* in addition to a variety of ECM proteins ([@B9]; [@B94]). Eap contains a central MAP domain that is presumed to bind fibronectin, *S. aureus* cells, and a variety of extracellular proteins ([@B62]; [@B39]; [@B36]). The ECM-binding protein (Emp) also mediates fibronectin-binding in *S. aureus* ([@B50]). Like Ebh, Emp is tightly associated with the bacterial cell surface despite the absence of an LPXTG motif. Notably, Emp exhibits broad affinity for ECM components, including fibronectin, fibrinogen, collagen, and vitronectin. This highlights an important problem inherent in the study of FnBPs: though they have long been studied with the assumption of single ligand-specificity, a multifunctional model of bacterial adhesins is emerging ([@B40]; [@B32]). For example, FnBPA binds to fibrinogen and elastin ([@B128]; [@B66]); Eap binds vitronectin, fibrinogen, and prothrombin ([@B62]; [@B39]); Aaa binds to vitronectin and fibrinogen ([@B42]; [@B47]). Given the limited number of cell wall-associated adhesion proteins and their importance in evasion of host immune responses, cell invasion and biofilm formation, it is expected that FnBPs have evolved to bind multiple ligands ([@B32]). Furthermore, the apparent functional redundancy of FnBPs makes it difficult to attribute definitive adhesion phenotypes.

While many of the FnBPs in *S. aureus* are conserved across staphylococci, other Gram-positive bacteria possess an entirely different collection of FnBPs. The human pathogen *S. pyogenes*, for example, expresses at least 11 additional distinct FnBPs ([@B43]). Perhaps the most studied of these is a set of homologous proteins, F1 and Sfb1 ([@B117]; [@B38]). As with many of the *S. aureus* FnBPs, both F1 and Sfb1 are cell wall-anchored. Another shared feature between *S. aureus* FnBPs and F1/Sfb1 is a series of central FnBRs similar to those observed in FnBPA/FnBPB ([@B93]). Like FnBPA/B, the FnBRs of F1/Sfb1 bind to fibronectin at the N-terminal FNI~1~-FNI~5~ region ([@B107]). In F1/Sfb1, a 43-amino acid N-terminal region also binds fibronectin, but at modules FNI~6~--FNI~9~ ([@B109]) (**Figure [2](#F2){ref-type="fig"}**).

Fibronectin-binding repeats with sequence similarity to those in *S. aureus* have been found in other FnBPs from *S. pyogenes*, including F2, FbaB, Sof, SfbX, and FbaA ([@B43]). F2 is similar to F1, though it lacks the domain for binding modules FNI~6~--FNI~9~ ([@B70]). FbaB shows homology to the C-terminal domain of protein F2 ([@B119]). Although serum opacity factor (Sof) contains functional FnBRs, an additional N-terminal opacity domain is necessary for cell binding ([@B100]). SfbX features a C-terminal array of four FnBRs. The *sfbX* gene, which occurs immediately downstream of *sof*, is found only in *sof*-positive streptococci ([@B58]). The dominant theme in this set of FnBPs is the role of FnBRs in binding the N-terminal domain of fibronectin (FNI~1~--FNI~5~). Furthermore, these proteins contain C-terminal LPXTG cell wall anchors.

A second subset of FnBPs in *S. pyogenes* and other streptococci do not possess the canonical FnBRs. These include the M1 protein, GAPDH, protein H, Shr, and Scl1. Protein M1 anchors to the cell wall by an LPXTG motif binds fibronectin with two N-terminal domains ([@B20]). Unlike the other FnBPs discussed, protein H binds to FNIII modules instead of FNI modules ([@B34]). Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) also shows fibronectin-binding activity ([@B95]). Shr and Scl1 are relatively new additions to the non-FnBR subset of *S. pyogenes* FnBPs ([@B30]; [@B12]). The streptococcal surface enolase, a glycolytic pathway enzyme with plasminogen-binding capability, has been identified as a FnBP in *S. suis* ([@B96]; [@B27]). More recently a putative peptidase (Ssa) in *S. suis* and an endopeptidase (PepO) in *S. pneumoniae* have been implicated in fibronectin-binding ([@B1]; [@B75]). The discovery of these novel FnBPs represents a new paradigm in which bacterial proteins with other known functions double as FnBPs.

A 54-kDa protein was originally identified in streptococci and termed Fbp54 after it was shown to bind to fibronectin and fibrinogen, despite a lack of typical fibronectin-binding sequences ([@B19]). Since the initial characterization of Fbp54, distant homologs have been found among a variety of host-associated bacteria including streptococci, lactococci, lactobacilli, clostridia, listeria, pneumococci, enterococci, and bacilli. There has been inconsistency in the naming of Fbp54 homologs, such as PavA in *S. pneumoniae*, FbpA in *S. gordonii*, and FbpS is *S. suis* ([@B49]; [@B14]; [@B21]). This has led to confusion about the prevalence and identity of this FnBP. The Gram-positive pathogen *C. perfringens*, a common cause of wound-associated infections and food poisoning, also expresses an Fbp54 homolog (FbpA). FbpA recognizes a non-canonical FNIII~9~-FNIII~10~ region of fibronectin ([@B64], [@B65]). Despite its ubiquity, little is known about the binding mechanism of the Fbp54 family of FnBPs in other organisms.

Host Interactions
=================

The ability to attach to the surface of host cells, followed by entry and proliferation, can lead to severe host diseases specifically mediated by FnBPs ([@B59]; [@B72]; [@B43]; [@B101]; [@B116]). Pathogenic strains of staphylococci are one of the most common causes of skin and bloodstream infections in the United States ([@B77]; [@B131]; [@B84]; [@B121]). Bacterial cells use FnBPs to form a three-component bridge between themselves and the host cell through attachment to fibronectin molecules, which are further attached to α~5~β~1~ integrins ([@B118]; [@B53]). The linkage between integrins and the bacteria-fibronectin complex brings about the recruitment of cell signaling molecules and a rearrangement of the cytoskeleton that facilitates host cell invasion ([@B48]). The absence of FnBPA/B in *S. aureus* leads to a nearly 500-fold reduction in the internalization of bacteria ([@B111]). Importantly, expression of *S. aureus* FnBPA in non-invasive *Lactococcus lactis* bacteria confers the ability to invade human endothelial cells ([@B45]).

The same mechanism of host cell invasion via integrin-binding is observed in streptococci ([@B74]; [@B83]). Protein F1 and Sfb1 of *S. pyogenes* interact with fibronectin on the surface of non-phagocytic cells to trigger bacterial internalization ([@B83]; [@B57]; [@B93]). Though not as essential as protein F1 and Sfb1, other FnBPs such as FbaA, FbaB, Ssa, and protein M1 promote cell invasion ([@B43]; [@B75]). Because fibronectin interacts with integrin by means of its RGD peptide, it has been proposed that FnBPs with the RGD integrin attachment domain, such as FbaB, interact directly with integrin ([@B73]).

Arguably the most prevalent FnBP, Fbp54 and its homologs (FbpA, FbpS, and PavA) play an important role in virulence-associated internalization ([@B49]). An *fbpA*-deficient mutant of *Listeria monocytogenes* exhibited a reduced ability to invade hepatocytes ([@B25]; [@B90]). A *pavA*-deficient mutant of *S. pneumoniae* exhibited a similar decrease in adherence and internalization ability ([@B99]). Recent evidence suggests that staphylococcal FnBPs are also required to form biofilms. A homolog of the 1.1-MDa *S. aureus* FnBP (Ebh) was identified in *S. epidermidis* and found to be sufficient and necessary for biofilm formation ([@B15]). The introduction of mutations into *fnbpA* and *fnbpB*, encoding FnBPA and FnBPB, reduced biofilm formation in multiple methicillin-resistant strains of *S. aureus* ([@B89]). A full deletion of *fnbpA* and *fnbpB* from *S. aureus* also reduced biofilm formation, highlighting reduced initial bacterial aggregation as the underlying mechanism ([@B80]). Further evidence suggests that low-affinity homophilic interactions between FnBPA domains on adjacent cells promote cell accumulation and contribute to biofilm formation ([@B44]).

In addition to exploiting fibronectin as a method of host cell attachment and invasion, bacterial FnBPs can modify the signaling activity of human fibronectin. Fragments of fibronectin are often found in the blood after injury or infection ([@B16]). These fragments are important for host cell signaling and have been linked to essential biological functions ([@B132]; [@B37]). Fibronectin fragments of 110 kDa stimulate human macrophages *in vitro*, significantly increasing output of TNF-alpha, FGF-1, IGF-1, and LIF ([@B123]). Fibronectin fragments can also influence monocyte behavior in HIV-1-infected patients ([@B124]). The role of fibronectin fragments in biological processes appears to be shaped by the domains present on the fibronectin fragment. For example, the alternatively spliced EIIIA domain is associated with cell motility and fibrosis. However, the EIIIA domain is non-essential for differentiation of hepatic stellate cells and portal fibroblasts to myofibroblasts ([@B88]).

Smaller sequences within fibronectin domains have also been linked with specific biological functions. A 13-residue stretch of fibronectin (FN13) is responsible for inducing matrix assembly in cultured cells. In the absence of this peptide, migration of tumorigenic cells is inhibited ([@B18]). An N-terminal 29-kDa fragment of fibronectin increases phosphorylation of ERK1/2, p38 and JNK1/2 protein kinases, leading to enhanced cartilage matrix damage ([@B24]). Larger fibronectin fragments of 50 and 140-kDa show less kinase activation, though all three fragments show significantly more activity than native fibronectin, which is inactive in terms of cartilage degradation ([@B23]). In binding these fragments, FnBPs may interfere with host cell signaling. A 49-residue sequence of the F1 protein in *S. pyogenes* binds the N-terminal 70-kDa region of fibronectin and inhibits matrix assembly ([@B120]). This interaction illustrates the ability of FnBPs to block the activity of fibronectin fragments.

It is important to note that because fibronectin is produced at basolateral surfaces, bacteria must bypass the epithelial barrier to gain access. However, adenosine, a proinflammatory signaling molecule, induces transport of fibronectin to the apical surface where it is accessible to bacteria ([@B127]). Adenosine-induced apical display was shown to facilitate the adherence and consequent invasion of *Salmonella enterica*. By this mechanism, other signaling molecules could induce apical display of fibronectin, providing an ecological advantage to species with FnBPs.

Non-Pathogenic FnBPs
====================

In both pathogenic and commensal bacteria, host attachment allows access to nutrients, suitable environmental conditions, and interaction with the host immune system by promoting retention in a particular niche. The diverse array of FnBPs identified in pathogens is unparalleled in commensals, though some FnBPs are expressed in both pathogens and commensal species. The clearest example is Fbp54, which is found across a variety of host-associated commensals, as well as the probiotic species *Lactobacillus acidophilus*, *L. casei*, *L. plantarum*, *L. brevis*, *L. rhamnosus*, and *Bacillus subtilis* ([@B2]; [@B7]; [@B126]; [@B86]). Purified FbpA from *L. casei* exhibits a stronger affinity for immobilized fibronectin than soluble fibronectin --- a trend also seen in the FbpA homolog of *S. pneumoniae* ([@B49]; [@B86]). In *L. acidophilus*, a mutant with inactivated *fbpA* exhibited a significant decrease in adhesion to epithelial cells *in vitro* ([@B10]).

A subset of lactobacilli forms surface layers (S-layers) that are crystalline arrays self-assembling, proteinaceous subunits called S-layer proteins ([@B8]; [@B103]). S-layer proteins are important for protection, cell shape, immunomodulation, and adhesion ([@B103]; [@B10]; [@B54]; [@B76]). The S-layer protein in *L. brevis* (SlpA) binds fibronectin, while inactivation of the S-layer protein in *L. acidophilus* (SlpA) reduced binding to epithelial cells ([@B55]; [@B10]). Although SlpA has not been further investigated for specific fibronectin-binding, the recent identification of S-layer associated proteins (SLAPs) in *L. acidophilus* has led to the implication of an additional FnBP, termed FbpB ([@B61]; [@B51]). FbpB contains an FNIII domain, which bears homology to the FNIII domain of human fibronectin. This suggests that FbpB may interact with the self-binding region of fibronectin (FNI~1~--FNI~5~) known to target the FNIII domain ([@B125]). Strikingly, homologs of FbpB are found only within the S-layer-forming subset of gut-associated lactobacilli. The unique FnBPs of lactobacilli and other non-pathogens may possess distinctive mechanisms to bind fibronectin in competition with pathogens.

Concluding Remarks
==================

There appears to be fewer FnBPs in commensals than pathogens, but this is likely due to sampling bias: pathogen "virulence factors" have been studied more often than commensal adhesins. Consequently, commensal and probiotic FnBPs are less understood than the FnBPs in pathogenic bacteria. Due to the presence of so-called "virulence factors" in commensals, it may be more accurate to refer to bacterial adhesins as "niche factors," as suggested in [@B46]. It is proposed that attachment proteins be categorized as niche factors because they are found in both pathogens and commensals that occupy an identical niche. However, proteins unique to pathogens that play a significant role in pathogenesis, such as exotoxins or coagulases, would remain classified as virulence factors. Addressing these concerns will be important from a regulatory perspective, as the probiotic potential of gut microbes is being increasingly investigated.

Bacteria employ adhesins as a means of attachment to their ecological niches. Adhesins play an important role in competition between organisms on host cell surfaces. The evolution of diverse FnBPs that interact with distinct regions of human fibronectin would likely provide an advantage to a bacterial species. Advances in genome sequencing technologies will enable extensive characterization of FnBPs in a growing number of microorganisms. The continued investigation of FnBPs will enhance our understanding of their diversity and specificity.
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